ArticleEuropean journal of medical research2025
A genetic variant of the glutamate-cysteine ligase catalytic subunit is associated with susceptibility to ischemic stroke in the Chinese population.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Serum to Genome: γ-Glutamyltransferase Gene Family Variants Shape Ischemic Stroke Risk via Sex-Specific Gene-Environment Interactions.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundA pathogenetic factor of ischemic stroke (IS) is oxidative stress. As a rate-limiting enzyme constituent in the glutathione synthetic pathway, the glutamate-cysteine ligase catalytic subunit (GCLC) exerts a crucial effect on the redox homeostasis. Several studies have shown that variants of the GCLC gene are related to susceptibility to various diseases. However, the association between GCLC single nucleotide polymorphisms (SNPs) and IS susceptibility has rarely been explored in the Chinese population. This study investigated the correlation of GCLC SNPs with the IS susceptibility in a southern Han Chinese population.
methodsIn this study, 400 controls and 388 IS patients were enrolled, and clinical data were collected. Six polymorphisms at GCLC were genotyped using an SNPscan kit.
resultsThe results revealed that rs12524494 GG at GCLC was linked to a markedly lowered probability of IS development (GG vs. AA: adjusted OR = 0.42, 95% CI, 0.20-0.91, p = 0.027; GG vs. AG + AA: adjusted OR = 0.41, 95% CI, 0.19-0.86, P = 0.018). Lipid analysis results revealed lower high-density lipoprotein (HDL) levels (p = 0.017) along with higher triglyceride (TG) levels (p = 0.006) in IS patients with rs51008 GG. Moreover, higher homocysteine (Hcy) levels were detected in controls than in patients (p < 0.0001). Both controls and patients with rs12524494 GG had significantly lower Hcy levels than their counterparts who carried rs12524494 AA/AG (P < 0.05).
conclusionsThese results indicated that rs12524494 GG may be linked to decreasing IS susceptibility. The identified rs12524494 GG may serve as a potential biomarker for predicting IS susceptibility in the Chinese population, which could inform personalized medicine approaches for stroke prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.